OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
February 02, 2023
In part 2 of this article, results from the testing of a next generation convecdiff membrane are discussed.
January 02, 2023
The testing of new convecdiff membranes shows this material to be well suited for lab- and commercial-scale bind-and-elute applications.
October 02, 2022
Using a minimum valuable product and process approach would make it is possible to discipline and structure the development of biopharmaceuticals in the fastest way possible.
September 02, 2022
This article introduces the requirements for a biosimilar license in Brazil and addresses questions about their quality, safety, and efficacy.
July 02, 2022
The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.
September 02, 2021
Establishing analytical workflows for complex biopharmaceutical molecules can help predict their risk of degradation.
June 02, 2021
Controlling certain atmospheric conditions in a closed NGI processing chamber can reduce bioburden without disinfectants.
April 02, 2021
A series of minute virus of mice spiking studies were performed with a monoclonal antibody product and small-scale AEX membrane adsorbers to evaluate a range of critical processing conditions.
November 02, 2020
Continuous SEC was shown to increase productivity with the same product quality and yield.
June 01, 2020
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.